This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
23 Apr 2021

Neofact - Clinical evaluation of an applicator for surfactant administration

Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS. 
This study shows that the LISA method (less invasive administration) via Neofact® appears feasible. 

Neofact® makes surfactant application easy and can also be used at any gestational age.

https://pubmed.ncbi.nlm.nih.gov/33023914/

Neofact for surfactant administration for RDS in preterm and term neonates.

Mentioned Companies
Lyomark Pharma GmbH
View company profile